Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Commun ; 12(1): 2928, 2021 05 18.
Article in English | MEDLINE | ID: mdl-34006888

ABSTRACT

Small interfering RNA (siRNA) is an effective therapeutic to regulate the expression of target genes in vitro and in vivo. Constructing a siRNA delivery system with high serum stability, especially responsive to endogenous stimuli, remains technically challenging. Herein we develop anti-degradation Y-shaped backbone-rigidified triangular DNA bricks with sticky ends (sticky-YTDBs) and tile them onto a siRNA-packaged gold nanoparticle in a programmed fashion, forming a multi-functional three-dimensional (3D) DNA shell. After aptamers are arranged on the exterior surface, a biocompatible siRNA-encapsulated core/shell nanoparticle, siRNA/Ap-CS, is achieved. SiRNAs are internally encapsulated in a 3D DNA shell and are thus protected from enzymatic degradation by the outermost layer of YTDB. The siRNAs can be released by endogenous miRNA and execute gene silencing within tumor cells, causing cell apoptosis higher than Lipo3000/siRNA formulation. In vivo treatment shows that tumor growth is completely (100%) inhibited, demonstrating unique opportunities for next-generation anticancer-drug carriers for targeted cancer therapies.


Subject(s)
DNA/chemistry , Gene Transfer Techniques , Gold/chemistry , Metal Nanoparticles/chemistry , Neoplasms/genetics , RNA, Small Interfering/genetics , A549 Cells , Animals , DNA/genetics , Gene Silencing , HeLa Cells , Humans , MCF-7 Cells , Mice, Inbred BALB C , Mice, Nude , Neoplasms/metabolism , Neoplasms/therapy , RNA, Small Interfering/administration & dosage , RNA, Small Interfering/pharmacokinetics , Xenograft Model Antitumor Assays/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...